Elevated D-Dimer and Non-Glucocorticoid Therapies Risk Factors for Thromboembolic Events in Dermatomyositis: Study Dr.Niharika Harsha B10 Dec 2024 8:00 PM ISTA recent study found that the prevalence of thromboembolic events is increased in individuals with Dermatomyositis with elevated D-dimer levels and...
Systematic Review Finds Higher Risk of Thromboembolic Events Following First Dose of ChAdOx1-S Vaccine Dr. Garima Soni27 Aug 2024 8:00 PM ISTIndia: One of the COVID-19 vaccinations namely ChAdOx1-S is found to be associated with cerebral venous sinus thrombosis (CVS), and peripheral...
Incidence and potential risk factors and clinical impacts of incomplete device endothelialization MD Editorial Team23 March 2022 6:45 PM ISTAtrial fibrillation (AF) is the common risk factor of stroke. Oral anticoagulation is used to mitigate stroke risk in patient with non-valvular atrial...
NOACs better than aspirin for thromboembolic protection after VT ablation, JACC study. dr. Abhimanyu Uppal14 Oct 2021 9:00 AM ISTAnticoagulation after ventricular tachycardia (VT) catheter ablation (CA) has been standard of care for more than three decades, yet there are little...
Use of intravenous tranexamic acid not linked to thromboembolic events: JAMA Dr Satabdi Saha21 April 2021 5:00 PM ISTTranexamic acid (TXA) is an efficient antifibrinolytic agent; however, concerns remain about the potential adverse effects, particularly vascular...
